Thyroid cancer mortality statistics

Deaths

Deaths from thyroid cancer, 2014, UK

 

Proportion of all deaths

Percentage thyroid cancer is of total cancer deaths, 2014, UK

 

Age

Peak rate of thyroid cancer deaths, 2012-2014, UK

 

Trend over time

Thyroid cancer mortality rates have decreased by 46% since the early 1970s, UK

 

Thyroid cancer accounts for less than 1% of cancer deaths in the UK for males and females combined (2014) and is not among the 20 most common causes of cancer death.[1-3] In males, it is the 20th most common cause of cancer death in the UK (less than 1% of all male cancer deaths), whilst in females it is not among the 20 most common causes of cancer death in the UK (less than 1% of all female cancer deaths).[1-3]

In 2014, there were 376 thyroid cancer deaths in the UK: 154 (41%) in males and 222 (59%) in females, giving a male:female ratio of around 7:10.[1-3] The crude mortality rate Open a glossary item shows that there is less than 1 thyroid cancer death for every 100,000 males in the UK, and less than 1 for every 100,000 females.[1-3]

The European age-standardised mortality rates Open a glossary item (AS rates) do not differ significantly between the constituent countries of the UK for males or females.[1-3]

Thyroid Cancer (C73), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2014

England Wales Scotland Northern Ireland UK
Male Deaths 133 4 12 5 154
Crude Rate 0.5 0.3 0.5 0.6 0.5
AS Rate 0.6 0.3 0.5 0.8 0.6
AS Rate - 95% LCL 0.5 0.0 0.2 0.1 0.5
AS Rate - 95% UCL 0.7 0.5 0.9 1.5 0.7
Female Deaths 188 6 20 8 222
Crude Rate 0.7 0.4 0.7 0.9 0.7
AS Rate 0.7 0.4 0.7 0.9 0.7
AS Rate - 95% LCL 0.6 0.1 0.4 0.3 0.6
AS Rate - 95% UCL 0.8 0.6 1.0 1.6 0.8
Persons Deaths 321 10 32 13 376
Crude Rate 0.6 0.3 0.6 0.7 0.6
AS Rate 0.6 0.3 0.6 0.9 0.6
AS Rate - 95% LCL 0.6 0.1 0.4 0.4 0.6
AS Rate - 95% UCL 0.7 0.5 0.9 1.4 0.7

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS rate Open a glossary item

Thyroid cancer mortality rates throughout the UK show very little variation between health boundaries for both males and females.[4]

References

  1. Data were provided by the Office for National Statistics on request, November 2015. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregistrationsummarytables/previousReleases
  2. Data were provided by Information Services Division (ISD) Scotland on request, November 2015. Similar data can be found here: http://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/vital-events/vital-events-reference-tables
  3. Data were provided by the Northern Ireland Statistics and Research Agency on request, November 2015. Similar data can be found here: http://www.nisra.gov.uk/demography/default.asp2.htm
  4. European age-standardised mortality rate of thyroid cancer by local health authority in the UK, 2009-2011. These data were extracted from the UK Cancer Information Service, version 4.5b 001 on 29/10/2013.
Last reviewed:

Thyroid cancer mortality is strongly related to age, with the highest mortality rates being in older males and females. In the UK in 2012-2014, on average each year almost 6 in 10 (55%) deaths were in people aged 75 and over.[1-3]

Age-specific mortality rates rise gradually from around age 40-44 and more sharply from around age 60-64, with the highest rates in the 85-89 age group in females, and the 90+ age group in males. Mortality rates are significantly higher for females than for males in those aged 80-84, when the female:male ratio of age-specific rates (to account for the different proportions of females to males  in each age group) is around 16:10.[1-3]

Thyroid Cancer (C73), Average Number of Deaths per Year and Age-Specific Mortality Rates, UK, 2012-2014

For most cancer types, mortality by age largely reflects incidence and survival by age, e.g. typically, higher incidence and lower survival in older people results in higher mortality in older people.

References

  1. Data were provided by the Office for National Statistics on request, November 2015. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregistrationsummarytables/previousReleases.
  2. Data were provided by the Information Services Division (ISD) Scotland on request, November 2015. Similar data can be found here: http://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/vital-events/vital-events-reference-tables.
  3. Data were provided by the Northern Ireland Statistics and Research Agency on request, November 2015.Similar data can be found here: http://www.nisra.gov.uk/demography/default.asp2.htm.
Last reviewed:

Thyroid cancer mortality rates have decreased by 46% in the UK since the early 1970s.[1-3] Thyroid cancer mortality rates have decreased by 46% in the UK since the early 1970s.

For males, European Age-Standardised (AS) mortality rates Open a glossary item decreased by 35% between 1971-1973 and 2001-2003 and have since remained stable. For females, rates decreased by 52% between 1971-1973 and 1995-1997 and have since remained stable.

Over the last decade in the UK (between 2003-2005 and 2012-2014), thyroid cancer AS mortality rates have remained stable in the UK, for males and females combined and separately.[1-3]

Thyroid Cancer (C73), European Age-Standardised Mortality Rates, UK, 1971-2014

For most cancer types, mortality trends largely reflect incidence and survival trends, e.g. increased incidence without sufficient survival improvement results in increased mortality.

Thyroid cancer mortality rates have decreased overall for males aged 50-59 or 60-69 in the UK since the early 1970s, but have remained stable in the other broad age groups.[1-3] The largest decrease has been in males aged 50-59, with rates decreasing by 59% between 1971-1973 and 2012-2014.

Thyroid Cancer (C73), European Age-Standardised Mortality Rates, by Age, Males, UK, 1971-2014

Thyroid cancer mortality rates have decreased overall in females in most of the broad age groups in the UK since the early 1970s, but have remained stable  in females aged 0-24.[1-3] The largest decreases have been in women aged 50-59, with rates decreasing by around 65% between 1971-1973 and 2012-2014.

Thyroid Cancer (C73), European Age-Standardised Mortality Rates, by Age, Females, UK, 1971-2014

References

  1. Data were provided by the Office for National Statistics on request, November 2015. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregistrationsummarytables/previousReleases.
  2. Data were provided by the Information Services Division (ISD) Scotland on request, November 2015. Similar data can be found here: http://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/vital-events/vital-events-reference-tables.
  3. Data were provided by the Northern Ireland Statistics and Research Agency on request, November 2015. Similar data can be found here: http://www.nisra.gov.uk/demography/default.asp2.htm.
Last reviewed:

Thyroid cancer mortality rates are projected to rise by 7% in the UK between 2014 and 2035, to 1 death per 100,000 people by 2035.[1] This includes an increase for females and a drop for males.

For males, thyroid cancer European age-standardised (AS) Open a glossary item mortality rates in the UK are projected to fall by 5% between 2014 and 2035, to 1 death per 100,000 by 2035.[1] For females, rates are projected to rise by 17% between 2014 and 2035, to 1 death per 100,000 by 2035.[1]

Thyroid cancer (C73), Observed and Projected Age-Standardised Mortality Rates, by Sex, UK, 1979-2035

It is projected that 612 deaths from thyroid cancer (235 in males, 378 in females) will occur in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C73

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

There is no evidence for an association between thyroid cancer mortality and deprivation for either males or females in England.[1] England-wide data for 2007-2011 show European age-standardised Open a glossary item mortality rates are similar for both males and females living in the most deprived areas compared with the least deprived.[1]

Thyroid Cancer (C73), European Age-Standardised Mortality Rates by Deprivation Quintile, England, 2007-2011

The estimated deprivation gradient in thyroid cancer mortality between people living in the most and least deprived areas in England has not changed in the period 2002-2011.[1]

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for: UK, 2007-2011, ICD-10 C73

Deprivation gradient statistics were calculated using mortality data for 2007-2011. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

There were around 6,300 deaths from thyroid cancer in Europe in 2012 (0.4% of total cancer deaths). In Europe (2012), the highest World age-standardised Open a glossary item mortality rates for thyroid cancer are in Iceland for men and Russia for women; the lowest rates are in Malta and Montenegro for men and Luxembourg for women. UK thyroid cancer mortality rates are estimated to be the 6th lowest in males in Europe, and 9th lowest in females.[1] These data are broadly in line with Europe-specific data available elsewhere.[2]

There were around 37,800 deaths from thyroid cancer worldwide in 2012 (0.5% of total cancer deaths). Thyroid cancer mortality rates are highest in Melanesia and lowest in Northern Europe, but this partly reflects varying data quality worldwide.[1]

References

  1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed December 2013. 
  2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al.Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer (2013) 49, 1374-1403.
Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Rate this page:

Currently rated: 1.2 out of 5 based on 6 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page